Moderna begins study of COVID-19 vaccine in kids

Gulf Today Report 

Moderna Inc has begun administering its COVID-19 vaccine to children between six months to less than 12 years in a study, the company announced on Tuesday.

In the study, the effectiveness of mRNA-1273 administered in two doses, 28 days apart will be assessed. 

READ MORE 

Manila bans under 18 from being outdoors as virus cases surge

Ras Al Khaimah issues safety measures during Ramadan

UAE sends second shipment of COVID-19 vaccine to Gaza

The study intends to work with about 6,750 children in the United States and Canada.

The vaccine has already been authorized for emergency use in Americans who are aged 18 and older.

The study is done in collaboration between the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).